logo
Google Reviews Logo

317.636.6481

One Indiana Square, Suite 1400 Indianapolis, Indiana 46204

Make a Payment
logo
CONTACT US
CALL US
  • Home
  • Firm Overview
  • Our Attorneys
  • Practice Areas
    • Pharmaceutical Drug & Medical Device Litigation
    • Personal Injury
    • Sexual Abuse
    • Class Action
    • Medical Malpractice
    • Eminent Domain
    • Family Law
    • Business Services, Real Estate & Business Litigation
    • Bankruptcy, Creditor’s Rights, & Commercial & Business Law
    • Appellate Law
  • Firm News
    • News & Announcements
    • Alerts
  • Resources
    • Video Library
    • Blog
  • Contact Us
Google Reviews Logo

317.636.6481

One Indiana Square, Suite 1400 Indianapolis, Indiana 46204

Make a Payment
  • Home
  • Firm Overview
  • Our Attorneys
  • Practice Areas
    • Pharmaceutical Drug & Medical Device Litigation
    • Personal Injury
    • Sexual Abuse
    • Class Action
    • Medical Malpractice
    • Eminent Domain
    • Family Law
    • Business Services, Real Estate & Business Litigation
    • Bankruptcy, Creditor’s Rights, & Commercial & Business Law
    • Appellate Law
  • Firm News
    • News & Announcements
    • Alerts
  • Resources
    • Video Library
    • Blog
  • Contact Us

Home » FDA Limits Use of Nizoral Tablets and Warns of Potential for Fatal Injuries

FDA Limits Use of Nizoral Tablets and Warns of Potential for Fatal Injuries

The FDA issued a safety warning related to the use of oral Nizoral (ketoconazole) tablets for the treatment of fungal infections. The agency warns that use of Nizoral tablets can cause severe liver injuries and adrenal gland problems. It cautions that patients taking high doses of Nizoral for short periods of time, as well as those taking low doses for longer periods can suffer liver injury or disease. Nizoral tablets can also negatively impact a patient’s adrenal glands and cause a serious electrolyte imbalance.

Topical formulations of Nizoral have not been associated with liver or adrenal gland problems. Nizoral tablets can be prescribed to treat fungal infections and conditions such as thrush, athlete’s foot, dandruff, and ringworm.

The FDA warns that oral Nizoral use should be limited and used for treatment of fungal infections only when alternative therapies are not available. It also warns against using Nizoral tablets for patients with acute or chronic liver disease. The safety announcement which includes the warnings and limitations for this drug can be found on the FDA website.

If you or someone you care about has taken Nizoral tablets and suffered a serious injury, contact us. Our product liability attorneys have litigated thousands of product liability claims against pharmaceutical companies and medical device manufacturers and can advise you of your legal rights and options.

One Indiana Square Suite 1400
Indianapolis, Indiana 46204

Copyright ©  Cohen & Malad, LLP. All rights reserved.

Disclaimer  |  Privacy Policy

 

Schedule a free consultation Today
  • This field is for validation purposes and should be left unchanged.

Schedule a free consultation Today

  • This field is for validation purposes and should be left unchanged.

ALERTS

University of Southern California Agrees to $852 Million Settlement in Sexual Abuse Lawsuit

More than 700 women who claim University of Southern California campus gynecologist Dr. George Tyndall sexually abused .. Read More

SEE ALL ALERTS

In the News

Natalie A. Lyons Joins Class Action Practice at Cohen & Malad, LLP Six Cohen & Malad, LLP Attorneys Named to 2021 Indiana Super Lawyers Rising Stars List Thirteen Cohen & Malad, LLP Attorneys Named to 2021 Indiana Super Lawyers List
READ OUR NEWS